Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8976 - 9000 of 9424 in total
Vicriviroc, also known as SCH 417690 and SCH-D, is currently in clinical trials for the management of HIV-1. This pyrimidine based drug inhibits the interaction of HIV-1 with CCR5, preventing viral entry into cells. This drug was developed by Schering-Plough.
Investigational
Experimental
Afuresertib has been used in trials studying the treatment of Cancer and Neoplasms, Haematologic.
Investigational
Racecadotril has been investigated for the basic science and treatment of Diarrhea, Acute Diarrhea, and Acute Gastroenteritis.
Investigational
Alanyl Glutamine is under investigation in clinical trial NCT00338221 (Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition).
Investigational
Flumatinib has been used in trials studying the treatment of Myelogenous Leukemia, Chronic.
Investigational
ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.
Investigational
Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.
Investigational
Radotinib is under investigation for the treatment of Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Investigational
LY2886721 has been used in trials studying the basic science of Alzheimer's Disease.
Investigational
Laniquidar has been used in trials studying the treatment of Breast Cancer.
Investigational
Sulfobromophthalein or otherwise called bromsulphthalein is used as a test of liver function in humans .
Experimental
Experimental
Experimental
Experimental
Experimental
Displaying drugs 8976 - 9000 of 9424 in total